>BEC Abstracts from www.rationaltherapeutics.com. Dr. Nagourneys
>page
>#1070 BEC, A Mixture Of Solasodine Glycosides Reveals Cytotoxic
>Activity In Human Tumor Primary Culture Specimens: Pre-Clinical And
>Early Clinical Observations: YZ Su, DG Spall, MA Traill, C Kollin, C
>Chow, B. Sommers, S. Harper, D Horlick, SS Evans and RA Nagourney.
>Rational Theraputics, Inc. Long Beach, CA 90806 and OncoCare Cancer
>and Prostcare Clinic, Melbourne Australia.
>
>BEC, a mixture of glycoalkaloids extracted from Solanum Sodomaeum
>has shown activity in human tumor cell lines (Cham, BE. Canc. Lett.
>55:1990). To characterize the cytotoxicity of BEC for human tumors
>we applied an ex vivo cell death assay (EVA) in 23 fresh human tumor
>specimens. These included 8 Gynecologic (Gyn); 6 GI; 2 NSCLC; 2
>Breast (Bre) & 2 Sarcomas (Sar). In addition BEC activity was
>compared with other cytotoxic agents, including Cisplatin (CDDP);
>Doxorubicin (Dox), Paclitaxel (P); Nitrogen Mustard (NM);
>Vinorelbine (V); Topotecan (T); Etoposide (E); Gemcitabine (Gem) and
>Arsenic Trioxide (ARS). IC50 results for all 23 studies revealed a
>Median of 8.8 ug/ml and a Mean of 8.6 +/- 1 ug/ml (SEM). Mean IC50
>(ug/ml) by tumor type revealed Sar = 3.1; GI = 6.3; Bre = 7.8; Gyn =
>9.6; NSCLC = 14.5. A comparison of Mean IC50 values for BEC against
>other drugs revealed correlation coefficients (R values) for NM of
>0.76 (p<0.001) and for Gem of 0.45 (p<0.05) but no correlation with
>T, E, CDDP, P, V or ARS. Under Australian Special Access
>Experimental Drug Use Guidelines, 8 patients have received IV
>infusions of BEC at doses of 50 mg/m2 to 125 mg/m2, daily X 5 for 2
>weeks/month, for a total of 10 cycles to date. Toxicities have
>included rigors, fever, chemical phlebitis and reversible elevations
>of the transaminases. No hematologic, renal, cardiac or neurological
>toxicities were observed. Dose escalations and assessments of
>response continue. Conclusions: BEC reveals cytotoxic activity in
>human tumors. The ex vivo activity profile of BEC correlates with NM
>& Gem. Preliminary results indicate that BEC can be administered IV
>at up to 125 mg/m2. Cell death assays provide drug and disease
>specific information that can streamline novel agent development.
>Supported by The Vanguard Cancer Foundation and the Tina Robinson
>Cancer Research Fund.
- Forums
- ASX - By Stock
- SBP
- Solbec BEC: Can anyone decifer this biochemical al
SBP
solbec pharmaceuticals limited
Solbec BEC: Can anyone decifer this biochemical al
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online